CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not rec...
Phase 2
Boston, Massachusetts, United States and 1 other location
In this research study is looking to see how safe and effective belantamab mafodotin is in relapsed or refractory plasmablastic lymphoma or ...
Phase 2
Boston, Massachusetts, United States and 2 other locations
is in treating participants with relapse or refractory Follicular Lymphoma (FL).* The names of the study drugs involved in this research stu...
Phase 2
Boston, Massachusetts, United States and 1 other location
of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma...
Phase 2
Boston, Massachusetts, United States and 2 other locations
therapy in treating relapsed/refractory central nervous system (CNS) lymphoma, systemic lymphoma with concurrent CNS lymphoma...
Phase 1
Boston, Massachusetts, United States and 1 other location
This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma.The drugs invo...
Phase 1
Boston, Massachusetts, United States and 5 other locations
This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment.The name of the...
Phase 2
Boston, Massachusetts, United States
back) or refractory (cancer has not responded to treatment) B-cell Lymphoma and will be undergoing CAR T-cell Therapy.This research is being...
Boston, Massachusetts, United States and 1 other location
Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil,...
Phase 2
Boston, Massachusetts, United States and 3 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Boston, Massachusetts, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal